Effect of Eltrombopag Plus G-CSF on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
Panobinostat With Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
MK-2206 for Recurrent Malignant Glioma
- Status
- WITHDRAWN
- Phase
- PHASE2
FLT-PET Imaging of Brain Tumors in Children
- Status
- COMPLETED
- Phase
- PHASE2
FLT PET/CT for Staging, Target Definition and Assessment of Response to Therapy in Patients With Esophageal Cancer
- Status
- COMPLETED
- Phase
- NA
Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Individualized Stereotactic Body Radiotherapy of Liver Metastases
- Status
- COMPLETED
- Phase
- NA
IPI-504 in NSCLC Patients With ALK Translocations
- Status
- TERMINATED
- Phase
- PHASE2
Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease
- Status
- TERMINATED
- Phase
- PHASE2
Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease
- Status
- COMPLETED
- Phase
- N/A
Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
- Status
- TERMINATED
- Phase
- PHASE2
Metformin in Castration-Resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
STA-9090(Ganetespib) in Metastatic Ocular Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study Comparing Conventional Dose Combination RVD to High-Dose Treatment With ASCT in the Initial Myeloma up to 65 Years
- Status
- COMPLETED
- Phase
- PHASE3
Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2